With over 15 years of industry experience, Carolyn’s deep knowledge base will help fit UBC’s key East Coast accounts with the tailored solution for their specific need.
Contact Carolyn
What Sets UBC Apart?
UBC is a leader in the peri- & post-approval space and an industry expert in addressing safety and risk – with a unique approach to evidence generation that applies technology and real world data in a powerful way.
UBC works across all sizes and shapes of clients and has cultivated expertise within new molecular entities, specialty products, and the complex and unique demands developers face in the market of rare disease, orphan populations, and breakthrough therapies.
UBC understands what the regulatory agency is looking to do and we partner with our customers to guide them through these critical stages. Our methodological rigor in research is backed by experts in epidemiology, health policy, study design, and safety & risk management.
We are passionate about generating evidence that will prove the effectiveness, safety, and value of your product.
UBC's Solutions
Comprehensive Evidence Generation and Safety Services from Phase II through Post-Approval
Clinical Research
Global Clinical Development
PH II Clinical Trials
PH III Clinical Trials
Biometrics/Data Management
Peri- and Post-Approval Research
Phase IV Clinical Trials
Observational Research
Registries
Real World Evidence Generation
Virtual and Decentralized Studies
Safety and Risk Management
Pharmacovigilance
Risk Evaluation and Mitigation Strategies (REMS)
Risk Management Plans (EU-RMP)
Proactive Consulting
Technology & Resources
UBC Nexus
Integrated evidence development strategies for all study types
.png?width=50&height=50&name=white-linkedin-icon-930881%20(1).png "LinkedIn"){kind=icon}
